Mani Selvin Sundar Raj, Cherian Kripa Elizabeth, Kapoor Nitin, Thomas Athul, Eapen Jeethu Joseph, John Elenjickal Elias, Yusuf Sabina, Deborah Mercy, Rebekah Grace, Mohapatra Anjali, Alexander Suceena, David Vinoi George, Varughese Santosh, Paul Thomas V, Valson Anna T
Department of Nephrology, Christian Medical College, Vellore, India.
Department of Endocrinology, Christian Medical College, Vellore, India.
J Clin Densitom. 2025 Jan-Mar;28(1):101534. doi: 10.1016/j.jocd.2024.101534. Epub 2024 Oct 9.
There is a paucity of studies describing trabecular bone score (TBS) and bone mineral density (BMD) in kidney transplant (KT) recipients from developing countries.
This prospective observational study, from a tertiary teaching hospital in India assessed clinical, biochemical parameters including bone turnover markers and dual-energy X-ray absorptiometry (DXA) for BMD/TBS, hip structural analysis (HSA) and vertebral fracture assessment (VFA) at pre-KT, 3 months and 12 months post-KT.
A total of 53 KT recipients (90.6% living related) were recruited from August 2019 to March 2020 and followed till 1-year post-KT. The mean age was 33.9±10.4 years, 71.7% were males, and 11.5% had a history of pre-KT steroid use. Baseline fractures pre-KT as assessed by VFA were seen in 4 patients (7.5%). Mean BMD at spine and femoral neck and HSA variables at narrow neck and femoral shaft continued to decline till 3 months, but stabilised and reached pre-KT values 12 months post-KT. However, TBS and bone turn over markers continued to decline till 12 months post-KT (p value <0.001). New onset vertebral fractures were seen in 2(3.7%) and 1 patient (2.3%) at 3- and 12-months post-KT respectively. Pre-KT BMD significantly influenced bone health at 12 months post-KT, with patients in each quartile maintaining a similar trajectory over the follow up period (p < 0.001).
Despite significant improvement in kidney function following transplant, TBS and BMD of the spine significantly decreased mainly in the early post-KT period suggesting the effect of immunosuppressants on the bone. Strategies to improve bone health in KT patients are warranted.
关于发展中国家肾移植(KT)受者的小梁骨评分(TBS)和骨矿物质密度(BMD)的研究较少。
这项前瞻性观察研究来自印度一家三级教学医院,评估了KT术前、术后3个月和12个月时的临床、生化参数,包括骨转换标志物以及用于BMD/TBS、髋部结构分析(HSA)和椎体骨折评估(VFA)的双能X线吸收法(DXA)。
2019年8月至2020年3月共招募了53名KT受者(90.6%为亲属活体供肾),并随访至KT术后1年。平均年龄为33.9±10.4岁,71.7%为男性,11.5%有KT术前使用类固醇的病史。通过VFA评估,术前有4例患者(7.5%)存在基线骨折。脊柱和股骨颈的平均BMD以及窄颈和股骨干的HSA变量在术后3个月持续下降,但在术后12个月稳定并达到术前值。然而,TBS和骨转换标志物在术后12个月持续下降(p值<0.001)。分别在KT术后3个月和12个月发现2例(3.7%)和1例(2.3%)新发椎体骨折。术前BMD对KT术后12个月的骨骼健康有显著影响,各四分位数的患者在随访期间保持相似的变化轨迹(p<0.001)。
尽管移植后肾功能有显著改善,但TBS和脊柱BMD主要在KT术后早期显著下降,提示免疫抑制剂对骨骼有影响。有必要采取策略改善KT患者的骨骼健康。